{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T04:40:09Z","timestamp":1716180009668},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T00:00:00Z","timestamp":1384905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0080003","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T00:34:30Z","timestamp":1384994070000},"page":"e80003","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Plasma Interferon-Gamma-Inducible Protein-10 Levels Are Associated with Early, but Not Sustained Virological Response during Treatment of Acute or Early Chronic HCV Infection"],"prefix":"10.1371","volume":"8","author":[{"given":"Jordan J.","family":"Feld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail V.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Applegate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Hellard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana","family":"Sherker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Cherepanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Petoumenos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,11,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrgastro.2011.32","article-title":"Treatment of acute HCV infection","volume":"8","author":"J Grebely","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alfa-2b","volume":"345","author":"E Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/jac\/dkn346","article-title":"Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha","volume":"62","author":"J Wiegand","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"L Chen","year":"2005","journal-title":"Gastroenterology"},{"key":"ref5","first-page":"7034","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A","volume":"105","author":"M Sarasin-Filipowicz","year":"2008"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Feld JJ, Nanda S, Huang Y, Chen W, Cam M, <etal>et al<\/etal>.. (2007) Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response. Hepatology.","DOI":"10.1002\/hep.21853"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"D Ge","year":"2009","journal-title":"Nature"},{"key":"ref8","first-page":"1105","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet","volume":"41","author":"Y Tanaka","year":"2009"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"V Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"McGilvray I, Feld JJ, Chen L, Pattullo V, Guindi M, <etal>et al<\/etal>.. (2012) Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype. Gastroenterology 142: 1122\u20131131 e1121.","DOI":"10.1053\/j.gastro.2012.01.028"},{"key":"ref11","first-page":"499","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology","volume":"139","author":"M Honda","year":"2010"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"L Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"ref13","first-page":"374","article-title":"Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut","volume":"55","author":"M Diago","year":"2006"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/hep.21407","article-title":"IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection","volume":"44","author":"M Lagging","year":"2006","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/507307","article-title":"Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection","volume":"194","author":"AI Romero","year":"2006","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2893.2006.00838.x","article-title":"The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection","volume":"14","author":"M Zeremski","year":"2007","journal-title":"J Viral Hepat"},{"key":"ref17","first-page":"1523","article-title":"Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology","volume":"51","author":"G Askarieh","year":"2010"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, <etal>et al<\/etal>.. (2010) Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology 138: 123\u2013135 e121\u2013122.","DOI":"10.1053\/j.gastro.2009.09.019"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.24754","article-title":"Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection","volume":"55","author":"J Grebely","year":"2012","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Grebely J, Feld JJ, Applegate T, Matthews GV, Hellard M, <etal>et al<\/etal>.. (2013) Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology In Press.","DOI":"10.1002\/hep.26263"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/hep.26263","article-title":"Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection","volume":"57","author":"J Grebely","year":"2013","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.23850","article-title":"Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection","volume":"52","author":"J Grebely","year":"2010","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e17232","DOI":"10.1371\/journal.pone.0017232","article-title":"Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms","volume":"6","author":"M Lagging","year":"2011","journal-title":"Plos One"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3109\/00365548.2010.498019","article-title":"IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV","volume":"42","author":"K Falconer","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1099\/vir.0.041277-0","article-title":"Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection","volume":"93","author":"S Selvarajah","year":"2012","journal-title":"J Gen Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/hep.24056","article-title":"Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response","volume":"53","author":"JM Darling","year":"2011","journal-title":"Hepatology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1172\/JCI40594","article-title":"Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV","volume":"121","author":"A Casrouge","year":"2011","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, <etal>et al<\/etal>.. (2010) A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 139: 1586\u20131592, 1592 e1581.","DOI":"10.1053\/j.gastro.2010.07.005"},{"key":"ref29","unstructured":"Dill MT, Makowska Z, Duong FH, Merkofer F, Filipowicz M, <etal>et al<\/etal>.. (2012) Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C. Gastroenterology 143: 777\u2013786 e771\u2013776."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"B Rehermann","year":"2009","journal-title":"J Clin Invest"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bpg.2012.09.013","article-title":"Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection","volume":"26","author":"JJ Feld","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"JM Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1128\/MCB.00224-09","article-title":"Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18\/UBP43","volume":"29","author":"M Sarasin-Filipowicz","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.24189","article-title":"Interferon-beta and interferon-lambda signaling is not affected by interferon-induced refractoriness to interferon-alpha in vivo","volume":"53","author":"Z Makowska","year":"2011","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e22200","DOI":"10.1371\/journal.pone.0022200","article-title":"USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response","volume":"6","author":"V Francois-Newton","year":"2011","journal-title":"PLoS One"},{"key":"ref36","first-page":"859","article-title":"Interferon-lambda serum levels in hepatitis C. J Hepatol","volume":"54","author":"B Langhans","year":"2011"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.24580","article-title":"Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures","volume":"54","author":"S Marukian","year":"2011","journal-title":"Hepatology"},{"key":"ref38","first-page":"703","article-title":"Antiviral action of ribavirin in chronic hepatitis C. Gastroenterology","volume":"126","author":"JM Pawlotsky","year":"2004"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.21853","article-title":"Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response","volume":"46","author":"JJ Feld","year":"2007","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.23985","article-title":"Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models","volume":"53","author":"E Thomas","year":"2011","journal-title":"Hepatology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2010.03.037","article-title":"Ribavirin improves early responses to peginterferon through improved interferon signaling","volume":"139","author":"JJ Feld","year":"2010","journal-title":"Gastroenterology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nature03153","article-title":"Modelling how ribavirin improves interferon response rates in hepatitis C virus infection","volume":"432","author":"NM Dixit","year":"2004","journal-title":"Nature"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0080003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T03:59:52Z","timestamp":1716177592000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0080003"}},"subtitle":[],"editor":[{"given":"Golo","family":"Ahlenstiel","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,20]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0080003","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,20]]}}}